Our mission is to extend human healthspan, the period in one’s life unburdened by the disease of aging.
Working at the frontier of biotechnology and medicine, UNITY’s goal is to halt, slow or reverse age-associated diseases, while restoring human health.
Anacor Pharmaceuticals, Inc. KRISTINA BUROW Managing Director,
ARCH Venture Partners GRAHAM COOPER Chief Financial Officer and Chief Operating Officer,
Assembly Biosciences, Inc. NATHANIEL DAVID, PH.D. Co-Founder and President,
UNITY Biotechnology DAVID LACEY, M.D. Former Senior Vice President of Research,
Amgen KEITH R. LEONARD JR. Chairman and CEO,
UNITY Biotechnology ROBERT T. NELSEN Co-Founder and Managing Director,
ARCH Venture Partners CAMILLE SAMUELS Partner,
Nature Reviews Drug Discovery Anti-ageing pipleine starts to mature (August 3, 2018)